tenuigenin has been researched along with alpha-synuclein in 1 studies
| Studies (tenuigenin) | Trials (tenuigenin) | Recent Studies (post-2010) (tenuigenin) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
|---|---|---|---|---|---|
| 42 | 1 | 37 | 10,821 | 29 | 8,011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, JP; Gai, WP; Gong, XL; Halliday, G; He, Y; Huang, Y; Liang, ZG; Ren, XM; Wang, Q; Wang, X; Wang, XM; Wang, Y; Yang, J; Zhang, HB; Zheng, Y; Zhou, JX | 1 |
1 other study(ies) available for tenuigenin and alpha-synuclein
| Article | Year |
|---|---|
Tenuigenin attenuates α-synuclein-induced cytotoxicity by down-regulating polo-like kinase 3.
Topics: alpha-Synuclein; Cell Line, Tumor; Cell Survival; Down-Regulation; Drugs, Chinese Herbal; Humans; Parkinson Disease; Phosphorylation; Protein Serine-Threonine Kinases; Tumor Suppressor Proteins | 2013 |